Oncimmune Share News (ONC)

Oncimmune Information

Buy ONC Shares
Add ONC to Watchlist
Add ONC to Alert

Share Price Information for Oncimmune (ONC)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 25.60

Bid: 25.00

Ask: 26.20

Change: 0.10 (0.39%)

Spread: 1.20 (4.80%)

Open: 25.50

High: 0.00

Low: 0.00

Prev. Close: 25.50

Last checked at -

UK Shareholder Meetings Calendar - Next 7 Days

Mon, 16th Nov 2020 16:03

Tuesday 17 November
Dunelm Group PLC	AGM
BMO Real Estate Investments Ltd	AGM
Mulberry Group PLC	AGM
Scancell Holdings PLC	AGM
Physiomics PLC	AGM
Marwyn Value Investors Ltd	AGM
Craneware PLC	AGM
Shaftesbury PLC	GM re share issue resolutions
SIG PLC	GM re new remuneration policy
Wednesday 18 November
Beeks Financial Cloud Group PLC	AGM
Henderson Eurotrust PLC	AGM
Exillon Energy PLC	EGM re stock listing cancellation
Avingtrans PLC	AGM
Rainbow Rare Earths Ltd	AGM
Origin Enterprises PLC	AGM
Countrywide PLC	GM re proposed recapitalisation
Thursday 19 November
Close Brothers Group PLC	AGM
FW Thorpe PLC	AGM
William Hill PLC	GM re acquisition by Caesars Group
Jupiter UK Growth Investment Trust PLC	AGM
Finsbury Food Group PLC	AGM
Maestrano Group PLC	AGM
Randall & Quilter Investment Holdings Ltd	GM - re capital return
Infrastructure India PLC	AGM
Gresham House Energy Storage Fund PLC	GM re share issue, changes to investment policy
Friday 20 November
Salt Lake Potash Ltd	AGM
Diurnal Group PLC	AGM
Go-Ahead Group PLC	AGM
MC Mining Ltd	AGM
GSTechnologies Ltd	AGM
Gulf Investment Fund PLC	AGM
Monday 23 November
CPL Resources PLC	AGM
McBride PLC	AGM
Schroder Japan Growth Fund PLC	AGM
TR European Growth Fund PLC	AGM
Mountview Estates PLC	GM re appointment of director
Mitie Group PLC	GM re acquisition of Interserve Facilities Management
Rank Group PLC	GM re fundraising
Vast Resources PLC	GM
Oncimmune Holdings PLC	AGM

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

15 May 2019 15:27

Oncimmune distributor gets approval for 'EarlyCDT-Lung' in Israel

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced on Wednesday that its distributor for Israel, Best Medical Opinion, has received regulatory approval for the sale of the 'EarlyCDT-Lung' product in Israel.

10 May 2019 12:59

Oncimmune begins study to bring 'EarlyCDT-Lung' to China

(Sharecast News) - Oncimmune Holdings, alongside its partner Genostics Company, announced the start of a multi-centre case control study on early lung cancer detection for screening and nodules in the People's Republic of China on Friday, using an extended panel of autoantibodies to accommodate variations in the biomarkers expressed on cancer cells in Asian populations.

10 May 2019 11:36

Oncimmune And Genostics Initiate Trial Of EarlyCDT-Lung In China

LONDON (Alliance News) - Oncimmune Holdings PLC and Genostics Co Ltd on Friday said a multi-centre case control study on early lung cancer detection in China has started.The company said is

5 Apr 2019 15:10

Oncimmune inks distribution deal for lung cancer test in Portugal

(Sharecast News) - Personalised immunodiagnostics developer Oncimmune Holdings has signed an exclusive agreement for the distribution of its 'EarlyCDT-Lung' test kit in Portugal with Sabartech, its existing distributor in Spain, it announced on Friday.

5 Apr 2019 10:04

Oncimmune Signs Lung Cancer Test Kit Distribution Deal With Sabartech

LONDON (Alliance News) - Cancer diagnostics company Oncimmune Holdings PLC on Friday said it has signed an exclusive agreement for the distribution of its lung cancer test kit in Portgual with can

2 Apr 2019 10:50

Oncimmune strengthens scientific board with addition of Parag Mallick

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced the appointment of Dr Parag Mallick - an associate professor of radiology at Stanford University - to its scientific board on Tuesday.

19 Mar 2019 12:19

Oncimmune Buys Protagen Diagnostics In EUR4 Million All-Share Deal (ALLISS)

LONDON (Alliance News) - Cancer testing firm Oncimmune Holdings PLC said Tuesday it acquired protein biomarker laboratory Protagen Diagnostics AG for EUR4.1 million in an all-share will buy the of

19 Mar 2019 09:10

Oncimmune acquires Protagen Diagnostics in £4.11m deal

(Sharecast News) - Oncimmune Holdings has acquired Protagen Diagnostics for a total consideration of up to £4.11m, it announced on Tuesday, to be paid by the allotment of up to 2,635,910 Oncimmune ordinary shares at 156p each 0 a premium of 71% to the closing mid-market price on 18 March.

13 Feb 2019 10:45

Oncimmune Loss Widens In First Half On Administrative Costs

LONDON (Alliance News) - Cancer diagnostics business Oncimmune Holdings PLC on Wednesday said its loss widened in the first half its year on higher administrative expenses.In the six months

13 Feb 2019 09:20

Oncimmune Holdings' loss deepens on spiralling costs

(Sharecast News) - Oncimmune Holdings reported a widened interim loss on Wednesday as increases to research & development costs and administrative costs outweighed a rise in revenue.

20 Dec 2018 16:27

Oncimmune buoyed by US distribution deal for blood tests

(Sharecast News) - Oncimmune Holdings made gains on Thursday after it entered an agreement with America's Choice Provider Network to expand access to its EarlyCDT-Lung and EarlyCDT-Liver blood tests.

6 Dec 2018 17:39

Oncimmune Appoints Former Tusk Therapeutics CFO Matthew Hall To Board

LONDON (Alliance News) - Cancer diagnostics firm Oncimmune Holdings PLC on Thursday said its has appointed former Tusk Therapeutics Ltd Chief Financial Officer Matthew Hall as finance will replace

28 Nov 2018 11:57

Oncimmune signs sales deals in multiple countries for 'EarlyCDT-Lung' test

(Sharecast News) - Immunodiagnostics developer Oncimmune Holdings has signed exclusive agreements for the distribution of its 'EarlyCDT-Lung' test in Germany with hrmed.tech, in France with Eurobio Scientific, and in Italy with BSN, it announced on Wednesday.

31 Oct 2018 09:19

Oncimmune Annual Loss Deepens As Costs Hurt, Chases Cancer Test Deals

LONDON (Alliance News) - Oncimmune Holdings PLC said Wednesday its full year loss deepened on higher costs as it continues to chase new distribution deals for its cancer detection blood test the a

1 Oct 2018 12:47

Oncimmune inks multiple new distribution agreements

(Sharecast News) - Oncimmune revealed on Monday that it had signed multiple new distribution agreements for its EarlyCDT-Lung test as part of an early morning trading update.

Latest Share Chat

Oncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Login to your account

Quickpicks are a member only feature

Login to your account